Fecal Microbiota Transplantation in the Treatment of Inflammatory Bowel Disease

NCT04436874 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2020-06-19

No results posted yet for this study

Summary

Fecal microbiota transplantation (FMT), defined as infusion of feces from healthy donors to affected subjects, is a method to restore a balanced gut microbiota and has attracted great interest in recent years due to its efficacy and ease of use.

Conditions

  • Fecal Microbiota Transplantation

Interventions

DEVICE

endoscopy

transplant infusion of feces from healthy donors into affected subjects

Sponsors & Collaborators

  • Chinese University of Hong Kong

    collaborator OTHER
  • First Affiliated Hospital of Kunming Medical University

    lead OTHER

Principal Investigators

  • Y L Miao, doctor · First Affiliated Hospital of Kunming Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-23
Primary Completion
2021-12-23
Completion
2022-12-23

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04436874 on ClinicalTrials.gov